Validus Holdings, Ltd. (VR) Earns Buy Rating from Analysts at Buckingham Research

Investment analysts at Buckingham Research started coverage on shares of Validus Holdings, Ltd. (NYSE:VR) in a note issued to investors on Monday. The firm set a “buy” rating and a $52.00 price target on the insurance provider’s stock. Buckingham Research’s target price would suggest a potential upside of 18.13% from the stock’s current price.

A number of other equities analysts have also weighed in on the stock. ValuEngine upgraded shares of Validus Holdings from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Keefe, Bruyette & Woods set a $55.00 target price on shares of Validus Holdings and gave the stock a “hold” rating in a research report on Thursday, August 17th. BidaskClub lowered shares of Validus Holdings from a “sell” rating to a “strong sell” rating in a research report on Friday, August 18th. Finally, Zacks Investment Research lowered shares of Validus Holdings from a “buy” rating to a “hold” rating in a research report on Friday, July 7th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company’s stock. Validus Holdings presently has a consensus rating of “Hold” and a consensus price target of $56.29.

Validus Holdings (NYSE VR) traded up 5.622% during mid-day trading on Monday, hitting $46.495. 1,256,036 shares of the stock traded hands. The company has a market cap of $3.69 billion, a P/E ratio of 12.823 and a beta of 0.65. Validus Holdings has a 12 month low of $41.15 and a 12 month high of $58.76. The company’s 50 day moving average is $51.58 and its 200 day moving average is $53.75.

Validus Holdings (NYSE:VR) last issued its earnings results on Thursday, July 27th. The insurance provider reported $1.09 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.10. Validus Holdings had a net margin of 11.81% and a return on equity of 7.75%. The firm had revenue of $675.27 million during the quarter, compared to analyst estimates of $922.84 million. During the same quarter in the prior year, the business earned $0.66 earnings per share. On average, analysts expect that Validus Holdings will post $3.63 earnings per share for the current fiscal year.

WARNING: This story was reported by Markets Daily and is owned by of Markets Daily. If you are reading this story on another website, it was copied illegally and reposted in violation of US and international copyright & trademark legislation. The original version of this story can be accessed at https://www.themarketsdaily.com/2017/09/11/validus-holdings-ltd-vr-earns-buy-rating-from-analysts-at-buckingham-research.html.

In other Validus Holdings news, Director Matthew J. Grayson sold 10,000 shares of the stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $52.74, for a total transaction of $527,400.00. Following the completion of the transaction, the director now owns 91,393 shares in the company, valued at $4,820,066.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Matthew J. Grayson sold 30,000 shares of the stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $52.67, for a total transaction of $1,580,100.00. Following the transaction, the director now owns 61,393 shares of the company’s stock, valued at approximately $3,233,569.31. The disclosure for this sale can be found here. Insiders have sold 50,000 shares of company stock valued at $2,638,400 in the last quarter. 2.33% of the stock is owned by company insiders.

Hedge funds have recently added to or reduced their stakes in the business. IFP Advisors Inc lifted its position in Validus Holdings by 14.0% during the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock valued at $112,000 after purchasing an additional 265 shares during the last quarter. SG Americas Securities LLC bought a new position in Validus Holdings during the second quarter valued at $116,000. The Manufacturers Life Insurance Company lifted its position in Validus Holdings by 10.1% during the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after purchasing an additional 219 shares during the last quarter. BNP Paribas Arbitrage SA lifted its position in Validus Holdings by 93.7% during the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock valued at $138,000 after purchasing an additional 1,282 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Validus Holdings by 10.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock valued at $151,000 after purchasing an additional 278 shares during the last quarter. Institutional investors and hedge funds own 94.80% of the company’s stock.

Validus Holdings Company Profile

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Analyst Recommendations for Validus Holdings (NYSE:VR)

Receive News & Ratings for Validus Holdings Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus Holdings Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply